Navigation Links
Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Date:8/19/2007

ng the first six months of 2007, net cash used in operating activities was $16.8 million.

Conference Call and Webcast

Genta management will host a conference call and live audio webcast to discuss financial results and general corporate activities on August 7, 2007 at 8:00 am EDT.

Conference call information:

US/Canada call: 877-634-8606; conference code Genta Incorporated

International call: 706-679-3140; conference code Genta Incorporated

Webcast: http://www.genta.com/genta/InvestorRelation/events.html

The webcast will be archived for 30 days. Audio replay will be available approximately two hours after completion of the call, and will be archived for 30 days. Access numbers for this replay are: (800) 642-1687 (U.S./Canada) and (706) 645-9291 (International); conference ID number is 11209530.

About Genta

Genta Incorporated is a biopharmaceutical company with a diversified product portfolio that is focused on delivering innovative products for the treatment of patients with cancer. The Company's research platform is anchored by two major programs that center on oligonucleotides (RNA- and DNA- based medicines) and small molecules. Genasense(R) (oblimersen sodium) Injection is the Company's lead compound from its oligonucleotide program. The leading drug in Genta's small molecule program is Ganite(R) (gallium nitrate injection), which the Company is exclusively marketing in the U.S. for treatment of symptomatic patients with cancer related hypercalcemia that is resistant to hydration. Genta is partnered with IDIS (http://www.idispharma.com) on a program whereby both Ganite(R) and Genasense(R) are available on a "named- patient" basis in countries outside the United States. For more information about Genta, please visit our website at:

SOURCE Genta Incorporated

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Genta Announces Results of Phase 1 Study Using Genasense Administered by Intermittent Subcutaneous Injection
2. Genta Incorporated to Present Multiple Abstracts at the Annual Meeting of the American Society of Clinical Oncology
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... PARK, Calif. , Sept. 3, 2015 ... device company that is providing innovative evidence-based solutions for ... management will be presenting at the Morgan Stanley Global ... York City.  Nevro management is scheduled ... be accessible via a live audio webcast, accessible in ...
(Date:9/3/2015)... , Sept. 3, 2015  Ascendis Pharma ... stage biotechnology company that applies its innovative ... needs, today announced plans to present at ... Fargo Healthcare Conference in BostonDate: , Thursday, ... Bank of America Merrill Lynch Global Healthcare ...
(Date:9/3/2015)...  As part of its ongoing commitment to provide ... R. Katz , MD, MPH, cardiac surgeon and chief ... Institute implanted the first HeartMate 3 left ventricular assist ... as part of the prestigious MOMENTUM 3™ Clinical Trial. ... the United States—and the first in central Virginia—chosen to ...
Breaking Medicine Technology:Ascendis Pharma A/S to Present at Three Upcoming Investor Conferences 2Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 2Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 3Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 4
(Date:9/4/2015)... ... ... Many consumers are looking for a quick and convenient way to produce a hot remedy ... Cups provide a quick and simple way to brew a hot cup of cold remedy ... a result, they enhance comfort and health. The invention features a novel design that is ...
(Date:9/4/2015)... ... September 04, 2015 , ... ECC announces the ... created specifically for adults with intellectual, developmental and acquired disabilities. The first community, ... 30 cottage or “pocket” homes. In this community, adults will live safely and ...
(Date:9/4/2015)... ... September 04, 2015 , ... FiltersFast.com, ... Day offer that cannot be passed up. FiltersFast.com, will ship all orders ... and water filtration product replacements. Take advantage of this promotion now through September ...
(Date:9/3/2015)... ... 2015 , ... Allied Anesthesia is proud to announce a continuing partnership with ... exception. , St. Jude was recently named one of the nation’s top stroke centers ... of only 10 hospitals in the state to earn the distinction. , The ...
(Date:9/3/2015)... NH (PRWEB) , ... September 03, 2015 , ... ... new agreement with Amerinet Inc., a leading national healthcare solutions organization, to provide ... Epic EMR. , Through this agreement, Amerinet members will receive negotiated pricing on ...
Breaking Medicine News(10 mins):Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4Health News:FiltersFast.com Wows with a Long Labor Day Weekend Shipping Offer 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3Health News:E-Volve Health to Offer EMR Consulting Solutions to Amerinet Members 2
... for Increased Awareness of Disease, Funding for Research, SAN ... of 40,000 people in the U.S. who will lose,their lives ... will die from breast cancer. Yet, most people have never ... has no FDA approved treatment, no known cause and no ...
... BENSALEM, Pa., Oct. 31 Law Offices of Howard ... been filed on behalf,of purchasers of the common stock ... WCG ) between May 8, 2006 and October,24, 2007, ... in the United States District Court for the Middle ...
... Group Uses PETA Talking Points, Discourages Donations to,Legitimate ... health reporters,cover today,s report on global causes of ... nonprofit Center for Consumer Freedom is urging,them to ... animal,rights group calling itself "The Cancer Project." A ...
... Insurers Outline Features of their Countries, Models at,Event Sponsored ... Switzerland and The,Netherlands are among countries in Europe ... private sector plays a central role,in making care better ... countries have taken to cover all of their citizens, ...
... their risk of dying of the disease in half ... their cancer, compared to those who dont receive active ... diagnosed with localized prostate cancer, according to a study ... Therapeutic Radiology and Oncologys 49th Annual Meeting in Los ...
... says exercise and diet can lower chances of malignancies ... exercise and proper nutrition are key to reducing your ... adopt these practices, the better off you,ll be, a ... childbearing, breast-feeding, and adult height and weight also influence ...
Cached Medicine News:Health News:Goulet's Life Lost to Untreatable Lung Disease That Claims as Many Lives as Breast Cancer Each Year 2Health News:Consumer Alert: 'Cancer Project' Organization Is a Deceptive Animal Rights Group 2Health News:Forum Highlights Role of Private Sector in Achieving Universal Health Coverage in Europe 2Health News:Forum Highlights Role of Private Sector in Achieving Universal Health Coverage in Europe 3Health News:Radiation seed implant decreases risk of death over watchful waiting 2Health News:Obesity Linked to Increased Cancer Risk 2Health News:Obesity Linked to Increased Cancer Risk 3
For in vitro diagnostic use,with the IMMULITE 2000 Analyzer for,the quantitative measurement of prostatic,acid phosphatase (PAP) in serum, as an,aid in patient management....
For the quantitative measurement of human prostatic acid phosphatase (PAP) in human serum....
... Quality EEG recording is assured even in ... has high performance, high sensitivity amplifiers, ... rejection filter, shielded electrodes and a high ... Neurofax is a complete and ready ...
... MagPro is the high performance magnetic stimulator ... in medical research. , ,MagPro is able to ... precise studies of the field/nerve interface can be ... biphasic waveform and coil-current direction. , , , ...
Medicine Products: